AZ’s Fasenra study confirms robust efficacy in eosinophilic asthma

6th August 2020 Uncategorised 0

Drug reduced annual rate of asthma exacerbations by 49%

More: AZ’s Fasenra study confirms robust efficacy in eosinophilic asthma
Source: News